Superior sulcus non–small cell lung cancers (Pancoast tumors): Current outcomes after multidisciplinary management Journal Article
| Authors: | McLaughlin, K.; Tan, K. S.; Dycoco, J.; Chen, M. F.; Chaft, J. E.; Mankuzhy, N. P.; Rimner, A.; Aly, R. G.; Fanaroff, R. E.; Travis, W. D.; Bilsky, M.; Bains, M.; Downey, R.; Huang, J.; Isbell, J. M.; Molena, D.; Park, B. J.; Jones, D. R.; Rusch, V. W. |
| Article Title: | Superior sulcus non–small cell lung cancers (Pancoast tumors): Current outcomes after multidisciplinary management |
| Title Series: | Journal of Thoracic and Cardiovascular Surgery |
| Abstract: | Objective: Despite neoadjuvant chemoradiotherapy, Pancoast tumors still present surgical and oncologic challenges. To optimize outcomes, we used a multidisciplinary care paradigm with medical and radiation oncology, and involvement of spine neurosurgery for most T3 and all T4 tumors. Spine neurosurgery permitted resection of transverse process for T3 and vertebral body resection for T4 tumors. Methods: Retrospective analysis of single institution, prospective database of patients undergoing resection for cT3 4M0 Pancoast tumors. Patients were grouped as cT3 with combined resection with spine neurosurgery (T3 Neuro), cT3 without spine neurosurgery (T3 NoNeuro), and cT4. Overall survival, progression-free survival were analyzed by Kaplan-Meier and compared between groups using log-rank test. Cumulative incidence of local-regional and distant recurrence were compared using Gray test. P value <.05 was considered significant. Results: From 2000 to 2021, 155 patients underwent surgery: median age was 58 years, and 81 were (52%) men. Most patients received neoadjuvant platinum-based neoadjuvant chemoradiotherapy (n = 127 [82%]). Operations were 48 cT3 Neuro, 41 cT3 NoNeuro, 66 cT4. R0 resection was achieved in 49 (94%) cT3 NoNeuro, 35 (85%) cT3 Neuro, and 57 (86%) cT4 patients (P = .4). Complete or major pathologic response occurred in 71 (55%) patients. Lower local-regional cumulative incidence was seen in cT3 Neuro versus cT3 NoNeuro (P = .05) and after major pathologic response. Overall survival and progression-free survival were associated with complete response, pathologic stage, and nodal status but not cT category. Conclusions: This treatment paradigm was associated with a high frequency of R0 resection, complete response, and major pathologic response. cT3 and cT4 tumors had similar outcomes. Novel therapies are needed to improve complete response. © 2023 |
| Keywords: | middle aged; retrospective studies; neoadjuvant therapy; chemotherapy; cancer staging; neoplasm staging; neoplasm recurrence, local; radiation; carcinoma, non-small-cell lung; lung neoplasms; pathology; retrospective study; lung tumor; tumor recurrence; surgery; non small cell lung cancer; humans; human; male; female; pancoast tumors |
| Journal Title: | Journal of Thoracic and Cardiovascular Surgery |
| Volume: | 166 |
| ISSN: | 0022-5223 |
| Publisher: | Mosby Elsevier |
| Date Published: | 2023-12-01 |
| Start Page: | 1477 |
| End Page: | 1487.e8 |
| Language: | English |
| DOI: | 10.1016/j.jtcvs.2023.08.023 |
| PROVIDER: | scopus |
| PUBMED: | 37611845 |
| PMCID: | PMC11229055 |
| DOI/URL: | |
| Notes: | The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PubMed record and PDF. Corresponding MSK author is Valerie W. Rusch -- Kaitlin Mcloughlin's last name is misspelled in the publication -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work